acial and social injustices and inequities have long plagued society and the health of communities of color across the United States. Our team at Johnson & Johnson recently announced Our Race to Health Equity—a bold aspiration to help eradicate racial and social injustice as a public health threat by eliminating health inequities for people of color.
Investing in community-based solutions developed for the community by the community is an essential component to closing the racial health and mortality gap. We’re launching the Johnson & Johnson Health Equity Innovation Challenge to seek and accelerate innovations that have the potential to advance health equity.
The Challenge aims to support potential innovative solutions from local entrepreneurs, innovators and local community-based organizations – beginning in six cities where Black and Hispanic communities experience significant health inequities: Chicago, Detroit, Los Angeles, New Orleans, New York City and Philadelphia. A local approach to achieving health equity requires investing in the people driving change within their own communities. Johnson & Johnson will award funding to selected applicants from a pool of at least $1,000,000, as well as potentially provide:
The opportunities for change, founded in innovation, are boundless. Our goal is to bring transformative potential solutions one idea at a time, to one community at a time.
A group of external experts with experience in public health, healthcare delivery, advocacy, entrepreneurship and academia will review local innovators’ submissions with the aim of ensuring a relevant, localized and independent assessment. Each community innovator’s application will be evaluated based on the ability to meet the following criteria:
1 Mentorship, including subject-matter assistance, may be provided if requested and if such assistance does not present any legal or compliance issues for the Johnson & Johnson Health Equity Innovation Challenge. Any mentorship will be non-binding on the Award recipient and will in no way be construed as directing the use of Award Funds by the Award recipient.
2 As appropriate by expertise and/or regulatory considerations.
3 Submitters should be located within defined greater metropolitan areas of Chicago, Detroit, Los Angeles, New Orleans, New York and Philadelphia.